The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

Though more cases are likely undiagnosed, over 15 million people in the United States have chronic obstructive pulmonary disease (COPD), and 37 million are estimated to have chronic kidney disease ...

Chronic obstructive pulmonary disease (COPD) and acute bronchitis both cause lung irritation and inflammation. They can trigger similar symptoms, including coughing, chest pain, and fatigue. Acute ...

I’M Dr Suraj Kukadia, known as Dr Sooj, an NHS GP who has seen how life-changing COPD can be. As the colder months set in, I ...

More than 50% of adults with low pulmonary function are undiagnosed and unaware that they have COPD. Alpha-1 antitrypsin deficiency (AATD) is also a rare genetic disorder that causes COPD. 4 Alpha-1 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2026 GOLD report newly highlights disease activity ...

In May 2025, the FDA approved mepolizumab (Nucala) as a treatment for chronic obstructive pulmonary disease (COPD). Before any drug gets near a pharmacy shelf, it starts with years of basic science ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...